1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ULTRAGENYX PHARMACEUTICAL INC.
Ultragenyx Pharmaceutical Inc. XNAS: RARE
31.82 0.54 (1.73%)
1.3M
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Ultragenyx Pharmaceutical Inc. is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details

Ultragenyx Pharmaceutical Inc. - RARE - stock price prediction, stock price target, analyst ratings from 20 analysts

Ultragenyx Pharmaceutical Inc. has a share price target of US$ 87, revenue growth forecast of 17.4%, and profit growth estimate of 10.3% for FY25, based on top 20 analyst calls.